VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Accumulated Depreciation (2011 - 2026)

VivoSim Labs (VIVS) posted quarterly Accumulated Depreciation of $1.7 million for Q1 2026, up 14.0% year-over-year from $1.5 million in Q1 2025, and up 14.0% quarter-over-quarter from $1.5 million in Q1 2025.

VivoSim Labs (VIVS) Accumulated Depreciation (2011 - 2026) Analysis & Trends

VivoSim Labs' Accumulated Depreciation history runs 16 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • In Q1 2026, Accumulated Depreciation rose 14.0% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 14.0% YoY), while the FY2026 annual figure was $1.7 million, up 14.0% from the prior year.
  • Accumulated Depreciation for Q1 2026 stood at $1.7 million, up from $1.5 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $1.7 million in Q1 2026, with the low at $1.1 million in Q1 2022.
  • The 5-year median for Accumulated Depreciation is $1.3 million (2023), against an average of $1.4 million.
  • The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation declined 1.41% in 2024, then rose 20.91% in 2025.
  • VivoSim Labs' Accumulated Depreciation stood at $1.1 million in 2022, then increased by 19.14% to $1.3 million in 2023, then dropped by 1.41% to $1.3 million in 2024, then climbed by 20.91% to $1.5 million in 2025, then increased by 14.0% to $1.7 million in 2026.
  • Business Quant data shows VIVS's Accumulated Depreciation at $1.7 million in Q1 2026, $1.5 million in Q1 2025, and $1.3 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 VivoSim Labs 1.49 Mn 1.49 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.73 Mn
Mar 31, 2025 1.52 Mn
Mar 31, 2024 1.26 Mn
Mar 31, 2023 1.28 Mn
Mar 31, 2022 1.07 Mn
Mar 31, 2021 1.00 Mn
Mar 31, 2020 415,000.00
Mar 31, 2019 4.58 Mn
Mar 31, 2018 4.07 Mn
Mar 31, 2017 2.92 Mn
Mar 31, 2016 1.81 Mn
Mar 31, 2015 1.00 Mn
Mar 31, 2014 574,000.00
Mar 31, 2013 270,000.00
Dec 31, 2012 192,000.00
Dec 31, 2011 148,000.00